Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive 
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates 
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White 
SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
Trip.com Shares Tumble After Q1 Profit Drops and Weak Revenue Growth Outlook 
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence 
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom 
Nissan Halts Electric Qashqai Development Amid EV Market Challenges 
KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal 
COPENHAGEN, Denmark, Feb. 26, 2016 -- Zealand informs that its management will present the company and host investor meetings at the following healthcare and biotech investor forums in March and April 2016, taking place in London, Paris and New York, respectively.
See the full announcement in the attachment below.
For further information, please contact:
Hanne Leth Hillman, Senior Vice President for Investor Relations and Communications
Tel: +45 50 60 36 89, email: [email protected]
Attachments:
02-16_0226 Investor News - Zealand conference attendance March and April 2016- ENG_Final.pdf
